OCUL
Ocular Therapeutix, IncCompany with tickers: OCUL
CIK
1393434
CUSIP
67576A100
Shares Outstanding
218,960,358
13F Activity (30d)
225 filings
222 filers
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-05-28 | Dugel Pravin | Director, See Remarks | Gift | 394,696 |
| 2026-05-28 | Dugel Pravin | Director, See Remarks | Gift | 394,696 |
| 2026-05-26 | Nayak Sanjay | Chief Strategy Officer | Sell | 1,858 |
| 2026-05-26 | Heier Jeffrey S. | Chief Scientific Officer | Sell | 3,018 |
| 2026-05-26 | Kaiser Peter | Chief Development Officer | Sell | 2,967 |
| 2026-05-26 | Dugel Pravin | Director, See Remarks | Sell | 21,156 |
| 2026-04-09 | Dugel Pravin | Director, See Remarks | Gift | 394,696 |
| 2026-04-09 | Dugel Pravin | Director, See Remarks | Gift | 394,696 |
| 2026-04-09 | Dugel Pravin | Director, See Remarks | Other | 300,115 |
| 2026-02-23 | Kaiser Peter | Chief Development Officer | Sell | 2,810 |
| 2026-02-23 | Dugel Pravin | Director, See Remarks | Other | 300,115 |
| 2026-02-23 | Dugel Pravin | Director, See Remarks | Sell | 20,056 |
| 2026-02-23 | Heier Jeffrey S. | Chief Scientific Officer | Sell | 3,057 |
| 2026-02-23 | Nayak Sanjay | Chief Strategy Officer | Sell | 1,759 |
| 2026-02-20 | LINDSTROM RICHARD L MD | Director | Buy | 60,229 |
| 2026-02-20 | Waheed Nadia | Chief Medical Officer | Sell | 3,510 |
| 2026-02-12 | Notman Donald | Chief Operating Officer | Sell | 11,446 |
| 2026-02-12 | Nayak Sanjay | Chief Strategy Officer | Sell | 10,348 |
| 2026-02-12 | Dugel Pravin | Director, See Remarks | Other | 300,115 |
| 2026-02-12 | Dugel Pravin | Director, See Remarks | Sell | 124,882 |
| 2026-02-12 | Waheed Nadia | Chief Medical Officer | Sell | 7,863 |
| 2026-02-04 | Notman Donald | Chief Operating Officer | Sell | 6,035 |
| 2026-02-02 | Notman Donald | Chief Operating Officer | Sell | 5,455 |
| 2026-01-21 | Robinson David Wayne | Global CCO | Award | 136,000 |
| 2026-01-21 | Robinson David Wayne | Global CCO | Award | 416,000 |
| 2026-01-21 | Robinson David Wayne | Global CCO | Other | 0 |
| 2026-01-20 | Robins Jason Shand | Interim CFO | Award | 33,000 |
| 2026-01-20 | Robins Jason Shand | Interim CFO | Other | 52,656 |
| 2026-01-20 | Robins Jason Shand | Interim CFO | Other | 0 |
| 2026-01-20 | Robins Jason Shand | Interim CFO | Other | 0 |
| 2026-01-02 | Saroj Namrata | Chief Business Officer | Award | 240,932 |
| 2026-01-02 | Saroj Namrata | Chief Business Officer | Award | 79,112 |
| 2026-01-02 | Waheed Nadia | Chief Medical Officer | Award | 240,932 |
| 2026-01-02 | Waheed Nadia | Chief Medical Officer | Award | 79,112 |
| 2026-01-02 | Heier Jeffrey S. | Chief Scientific Officer | Award | 79,112 |
| 2026-01-02 | Heier Jeffrey S. | Chief Scientific Officer | Award | 240,932 |
| 2026-01-02 | Notman Donald | Chief Operating Officer | Award | 79,112 |
| 2026-01-02 | Notman Donald | Chief Operating Officer | Award | 240,932 |
| 2026-01-02 | Anderman Todd | Chief Legal Officer | Award | 197,650 |
| 2026-01-02 | Anderman Todd | Chief Legal Officer | Award | 64,900 |
| 2026-01-02 | Meyers Steve Lawrence | Chief Commercial Officer | Award | 64,900 |
| 2026-01-02 | Meyers Steve Lawrence | Chief Commercial Officer | Award | 197,650 |
| 2026-01-02 | Nayak Sanjay | Chief Strategy Officer | Award | 197,650 |
| 2026-01-02 | Nayak Sanjay | Chief Strategy Officer | Award | 64,900 |
| 2026-01-02 | Kaiser Peter | Chief Development Officer | Award | 240,932 |
| 2026-01-02 | Kaiser Peter | Chief Development Officer | Award | 79,112 |
| 2025-11-26 | Dugel Pravin | Director, See Remarks | Gift | 49,754 |
| 2025-11-26 | Dugel Pravin | Director, See Remarks | Gift | 49,754 |
| 2025-11-24 | Kaiser Peter | Chief Development Officer | Sell | 3,007 |
| 2025-11-24 | Heier Jeffrey S. | Chief Scientific Officer | Sell | 3,469 |
| 2025-11-24 | Nayak Sanjay | Chief Strategy Officer | Sell | 1,878 |
| 2025-11-24 | Dugel Pravin | Director, See Remarks | Sell | 19,530 |
| 2025-11-05 | Saroj Namrata | Chief Business Officer | Sell | 25,865 |
| 2025-10-08 | Anderman Todd | Chief Legal Officer | Sell | 11,132 |
| 2025-10-02 | Kaiser Peter | Chief Development Officer | Sell | 9,653 |
| 2025-10-02 | Heier Jeffrey S. | Chief Scientific Officer | Sell | 10,502 |
| 2025-09-09 | Dugel Pravin | Director, See Remarks | Gift | 49,754 |
| 2025-09-09 | Dugel Pravin | Director, See Remarks | Gift | 49,754 |
| 2025-09-09 | Dugel Pravin | Director, See Remarks | Other | 250,361 |
| 2025-09-02 | Notman Donald | Chief Operating Officer | Sell | 1,066 |
| 2025-08-25 | Nayak Sanjay | Chief Strategy Officer | Sell | 1,885 |
| 2025-08-25 | Kaiser Peter | Chief Development Officer | Sell | 3,011 |
| 2025-08-25 | Heier Jeffrey S. | Chief Scientific Officer | Sell | 3,063 |
| 2025-08-25 | Dugel Pravin | Director, See Remarks | Sell | 21,494 |
| 2025-08-25 | Dugel Pravin | Director, See Remarks | Other | 250,361 |
| 2025-08-12 | Waheed Nadia | Chief Medical Officer | Award | 122,923 |
| 2025-08-12 | Waheed Nadia | Chief Medical Officer | Award | 40,363 |
| 2025-08-11 | Dugel Pravin | Director, See Remarks | Gift | 250,361 |
| 2025-06-12 | Dugel Pravin | Director, See Remarks | Gift | 50,029 |
| 2025-06-11 | LINDSTROM RICHARD L MD | Director | Other | 43,559 |
| 2025-06-11 | LINDSTROM RICHARD L MD | Director | Award | 14,000 |
| 2025-06-11 | LINDSTROM RICHARD L MD | Director | Award | 44,000 |
| 2025-06-11 | Williams Leslie J. | Director | Award | 14,000 |
| 2025-06-11 | Williams Leslie J. | Director | Award | 44,000 |
| 2025-06-11 | Dugel Pravin | Director, See Remarks | Award | 2,750,000 |
| 2025-06-11 | Hong Seung Suh | Director | Award | 14,000 |
| 2025-06-11 | Hong Seung Suh | Director | Award | 44,000 |
| 2025-06-11 | RAINES MERILEE | Director | Award | 14,000 |
| 2025-06-11 | RAINES MERILEE | Director | Award | 44,000 |
| 2025-06-11 | Graves Adrienne L | Director | Award | 44,000 |
| 2025-06-11 | Graves Adrienne L | Director | Award | 14,000 |
| 2025-06-11 | Warden Charles M | Director | Award | 14,000 |
| 2025-06-11 | Warden Charles M | Director | Award | 44,000 |
| 2025-06-11 | Meyers Steve Lawrence | Chief Commercial Officer | Other | 0 |
| 2025-06-11 | Meyers Steve Lawrence | Chief Commercial Officer | Other | 0 |
| 2025-06-11 | Meyers Steve Lawrence | Chief Commercial Officer | Other | 0 |
| 2025-06-11 | Meyers Steve Lawrence | Chief Commercial Officer | Other | 152,728 |
| 2025-06-11 | Meyers Steve Lawrence | Chief Commercial Officer | Other | 0 |
| 2025-06-11 | Saroj Namrata | Chief Business Officer | Other | 200,000 |
| 2025-06-11 | Saroj Namrata | Chief Business Officer | Other | 0 |
| 2025-06-11 | Saroj Namrata | Chief Business Officer | Other | 0 |
| 2025-06-11 | Saroj Namrata | Chief Business Officer | Other | 0 |
| 2025-06-02 | Waheed Nadia | Chief Medical Officer | Sell | 13,861 |
| 2025-05-23 | Dugel Pravin | Director, See Remarks | Sell | 21,219 |
| 2025-05-23 | Nayak Sanjay | Chief Strategy Officer | Sell | 1,862 |
| 2025-05-23 | Kaiser Peter | Chief Development Officer | Sell | 2,974 |
| 2025-05-23 | Heier Jeffrey S. | Chief Scientific Officer | Sell | 3,024 |
| 2025-05-08 | LINDSTROM RICHARD L MD | Director | Buy | 10,000 |
| 2025-04-28 | Dugel Pravin | Director, See Remarks | Gift | 200,332 |
| 2025-02-24 | Heier Jeffrey S. | Chief Scientific Officer | Sell | 3,061 |